(Q34341546)

1 August 2017

1 reference

title

Barrett's-related esophageal adenocarcinoma: is chemoprevention a potential option? (English)

1 reference

1 August 2017

1 reference

Fennerty MB

1

1 reference

PubMed ID

11513166

1 August 2017

Triadafilopoulos G

series ordinal

2

1 reference

PubMed ID

11513166

1 August 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

The American Journal of Gastroenterology

1 August 2017

1 reference

1 August 2017

96

1 reference

1 August 2017

8

1 reference

1 August 2017

2302-2305

1 reference

Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study.

1 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.04033.X

Changing patterns in the incidence of esophageal and gastric carcinoma in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.04033.X

Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.04033.X

Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.04033.X

Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.04033.X

Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.04033.X

Induction of cyclooxygenase-2 by activated Ha-ras oncogene in Rat-1 fibroblasts and the role of mitogen-activated protein kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.04033.X

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.04033.X

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.04033.X

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.04033.X

10.1111/J.1572-0241.2001.04033.X

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11513166